DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...
For the third time in the last two years, Baxter has been hit with the FDA’s most serious label for a recall affecting its infusion pump systems. This time around, the Class I recall notice is linked ...